Bran and irritable bowel syndrome: The primary-care perspective

Digestive and Liver Disease

Volumn 38, Issue 10, 2006, Pages 737-740

  Miller, V ^a   Lea, R ^a   Agrawal, A ^a   Whorwell, P J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bran; Fibre; Irritable bowel syndrome; Primary care

Indexed keywords

ADULT; AGED; ARTICLE; BRAN; CONTROLLED STUDY; DETERIORATION; DIETARY FIBER; DISEASE EXACERBATION; FEMALE; HEALTH CARE DELIVERY; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT RESPONSE;

ADULT; AGED; DIETARY FIBER; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; TREATMENT OUTCOME;

EID: 33748496661     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.06.015     Document Type: Article

References (17)

1. Gralnek I.M., Hays R.D., Kilbourne A., Naliboff B., and Mayer E.A. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119 (2000) 654-660
2. Sandler R.S. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 99 (1990) 409-415
3. Everhart J.E., and Renault P.F. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 100 (1991) 998-1005
4. Longstreth G.F. Irritable bowel syndrome: a multibillion-dollar problem. Gastroenterology 109 (1995) 2029-2031
5. Switz D.M. What the gastroenterologist does all day. A survey of a state society's practice. Gastroenterology 70 (1976) 1048-1050
6. Russo M.W., Gaynes B.N., and Drossman D.A. A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol 29 (1999) 339-343
7. Talley N.J., Zinsmeister A.R., and Melton III L.J. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 142 (1995) 76-83
8. Wells N.E., Hahn B.A., and Whorwell P.J. Clinical economics review: irritable bowel syndrome. Aliment Pharmacol Ther 11 (1997) 1019-1030
9. Bellini M., Tosetti C., Costa F., Biagi S., Stasi C., Del Punta A., et al. The general practitioner's approach to irritable bowel syndrome: from intention to practice. Dig Liver Dis 37 (2005) 934-939
10. Klein K.B. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 95 (1988) 232-241
11. Burkitt D.P., Walker A.R., and Painter N.S. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet 2 (1972) 1408-1412
12. Francis C.Y., and Whorwell P.J. Bran and irritable bowel syndrome: time for reappraisal. Lancet 344 (1994) 39-40
13. Bijkerk C.J., de Wit N.J., Stalman W.A., Knottnerus J.A., Hoes A.W., and Muris J.W. Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management. Can J Gastroenterol 17 (2003) 363-368
14. Bijkerk C.J., Muris J.W., Knottnerus J.A., Hoes A.W., and de Wit N.J. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 19 (2004) 245-251
15. Hebden J.M., Blackshaw E., D'Amato M., Perkins A.C., and Spiller R.C. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. Am J Gastroenterol 97 (2002) 2315-2320
16. Spiller R.C. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 107 (1999) 91S-97S
17. Mertz H., Naliboff B., Munakata J., Niazi N., and Mayer E.A. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 109 (1995) 40-52